InSilico Medicine climbs on inclusion in Hang Seng Biotech Index
BUZZ-InSilico Medicine climbs on inclusion in Hang Seng Biotech Index ** Shares of InSilico Medicine Cayman TopCo 3696.HK climb 3.2% to HK$49.84, bucking a 1.2% fall in Hang Seng Biotech Index .HSI
** The AI developer in pharmaceuticals says it will be included as a constituent of the Hang Seng Biotech Index .HSBIO effective June 8 and the shares are tradable under the Southbound Stock Connect
** "This milestone is anticipated to introduce the company's shares to a broader range of index funds and core portfolios of institutional investors, which will help diversify the investor base, boost trading liquidity, and enhance resilience against risks" - co
** Co, in response to media report of its intention to obtain a secondary listing in Abu Dhabi, says it evaluates various post-listing capital operations from time to time but has not made a concrete decision on secondary listing at this stage
** YTD, stock up 31.4%, while benchmark Hang Seng Index .HSI down 1%
(Reporting by Donny Kwok)
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7